CLINICAL MICROBIOLOGY AND INFECTION, vol.26, no.1, 2020 (SCI-Expanded)
Objectives: The aim was to investigate the activity of ceftazidime/avibactam (CAZ/AVI) against carbapenem-resistant Klebsiella pneumoniae (CRKP) and identify the resistance mechanisms before CAZ/AVI coming to Chinese market.